Autor: "Behbakht K" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma.
Autorzy:: Watson ZL; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO, 80045, USA.
Yamamoto TM; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO, 80045, USA.
McMellen A; Cancer Biology Graduate Program, University of Colorado, Aurora, CO, 80045, USA.
Kim H; Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Hughes CJ; Medical Student Training Graduate Program, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Wheeler LJ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO, 80045, USA.
Post MD; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO, 80045, USA.; Department of Pathology, University of Colorado School of Medicine, Aurora, CO, 80045, USA.
Behbakht K; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO, 80045, USA.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO, 80045, USA.
Bitler BG; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO, 80045, USA. .; Pokaż więcej
Źródło:: Clinical epigenetics [Clin Epigenetics] 2019 Nov 27; Vol. 11 (1), pp. 165. Date of Electronic Publication: 2019 Nov 27.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Drug Resistance, Neoplasm*
Cystadenocarcinoma, Serous/*genetics
Histocompatibility Antigens/*genetics
Histone-Lysine N-Methyltransferase/*genetics
Ovarian Neoplasms/*genetics
Phthalazines/*pharmacology
Piperazines/*pharmacology
Poly(ADP-ribose) Polymerase Inhibitors/*pharmacology
Animals ; Cell Line, Tumor ; Cystadenocarcinoma, Serous/drug therapy ; Cystadenocarcinoma, Serous/pathology ; Disease Progression ; Female ; Gene Expression Profiling/methods ; Histones/metabolism ; Humans ; Mass Spectrometry ; Mice ; Neoplasm Grading ; Ovarian Neoplasms/drug therapy ; Ovarian Neoplasms/pathology ; Sequence Analysis, RNA ; Xenograft Model Antitumor Assays

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer.
Autorzy:: Wheeler LJ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Watson ZL; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Qamar L; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Yamamoto TM; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Post MD; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Berning AA; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Spillman MA; Gynecologic Oncology, Texas A&M University Medical School, Baylor University Medical Center, Dallas, TX, USA.
Behbakht K; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Bitler BG; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. .; Pokaż więcej
Źródło:: Oncogenesis [Oncogenesis] 2018 Nov 26; Vol. 7 (11), pp. 92. Date of Electronic Publication: 2018 Nov 26.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Claudin-4 activity in ovarian tumor cell apoptosis resistance and migration.
Autorzy:: Hicks DA; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Denver, Anschutz Medical Campus, Mail Stop 8613, 12700 E. 19th Avenue, Aurora, Colorado, 80045, USA.
Galimanis CE; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Denver, Anschutz Medical Campus, Mail Stop 8613, 12700 E. 19th Avenue, Aurora, Colorado, 80045, USA.
Webb PG; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Denver, Anschutz Medical Campus, Mail Stop 8613, 12700 E. 19th Avenue, Aurora, Colorado, 80045, USA.
Spillman MA; Texas Oncology, Sammons Cancer Center, Baylor University Medical Center, 3410 Worth Street, Dallas, Texas, 75246, USA.
Behbakht K; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Denver, Anschutz Medical Campus, Mail Stop 8613, 12700 E. 19th Avenue, Aurora, Colorado, 80045, USA.
Neville MC; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Denver, Anschutz Medical Campus, Mail Stop 8613, 12700 E. 19th Avenue, Aurora, Colorado, 80045, USA.
Baumgartner HK; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Denver, Anschutz Medical Campus, Mail Stop 8613, 12700 E. 19th Avenue, Aurora, Colorado, 80045, USA. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2016 Oct 11; Vol. 16 (1), pp. 788. Date of Electronic Publication: 2016 Oct 11.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Apoptosis/*genetics
Cell Movement/*genetics
Claudin-4/*genetics
Ovarian Neoplasms/*genetics
Animals ; Caspase 3/metabolism ; Cell Line, Tumor ; Cell Survival/genetics ; Claudin-4/metabolism ; Disease Models, Animal ; Female ; Gene Expression Regulation, Neoplastic ; Heterografts ; Humans ; Immunohistochemistry ; Mice ; Ovarian Neoplasms/metabolism ; Ovarian Neoplasms/pathology ; RNA Interference ; RNA, Small Interfering/genetics ; Tumor Burden

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Influence of Gelatin-Thrombin Matrix Tissue Sealant on Bacterial Colony Formation and Risk of Pelvic Infection.
Autorzy:: Jarrett MJ; Research Track, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Vázquez-Torres A; Department of Immunology and Microbiology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045, USA.
Frank DN; Division of Infectious Diseases, Department of Medicine, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045, USA.
McCollister BD; Division of Infectious Diseases, Department of Medicine, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045, USA.
Henthorn PK; Research Track, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Ir D; Division of Infectious Diseases, Department of Medicine, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045, USA.
Sheeder J; Division of Family Planning, Department of OB/GYN, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045, USA.
Guy MS; Division of Gynecologic Oncology, Department of OB/GYN, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045, USA.
Anwar HQ; Division of Gynecologic Oncology, Department of OB/GYN, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045, USA.
Behbakht K; Division of Gynecologic Oncology, Department of OB/GYN, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045, USA.; Pokaż więcej
Źródło:: Infectious diseases in obstetrics and gynecology [Infect Dis Obstet Gynecol] 2016; Vol. 2016, pp. 2649708. Date of Electronic Publication: 2016 Apr 21.
Typ publikacji:: Journal Article
MeSH Terms:: Gelatin*
Thrombin*
Hysterectomy/*adverse effects
Pelvic Infection/*etiology
Pelvic Infection/*prevention & control
Tissue Adhesives/*adverse effects
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Colony Count, Microbial ; Escherichia coli/isolation & purification ; Female ; Hemostasis, Surgical/adverse effects ; Hemostasis, Surgical/methods ; Humans ; Middle Aged ; Pelvic Infection/microbiology ; Postoperative Complications/etiology ; Postoperative Complications/microbiology ; Postoperative Complications/prevention & control ; Risk Factors ; Vagina/microbiology ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Awareness of symptoms and risk factors of ovarian cancer in a population of women and healthcare providers.
Autorzy:: Goldstein CL; Loretto Heights School of Nursing at Regis University, Denver, CO.
Susman E; Department of Psychology at the Metropolitan State University of Denver in Colorado.
Lockwood S; Division of Undergraduate Nursing Studies, Harris College of Nursing and Health Sciences, Texas Christian University in Fort Worth.
Medlin EE; University of Wisconsin Hospital and Clinics, Madison, WI.
Behbakht K; School of Medicine at the University of Colorado Denver Anschutz Medical Campus, Aurora, CO.; Pokaż więcej
Źródło:: Clinical journal of oncology nursing [Clin J Oncol Nurs] 2015 Apr; Vol. 19 (2), pp. 206-12.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Clinical Competence*
Health Knowledge, Attitudes, Practice*
Health Personnel*
Women*
Ovarian Neoplasms/*diagnosis
Adult ; Female ; Humans ; Middle Aged ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Retrospective analysis of survival improvement by molecular biomarker-based personalized chemotherapy for recurrent ovarian cancer.
Autorzy:: Kim Y; Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, United States of America.
Guntupalli SR; University of Colorado Cancer Center, University of Colorado Denver, Aurora, Colorado, United States of America.
Lee SJ; Konkuk University School of Medicine, Seoul, Korea.
Behbakht K; University of Colorado Cancer Center, University of Colorado Denver, Aurora, Colorado, United States of America.
Theodorescu D; University of Colorado Cancer Center, University of Colorado Denver, Aurora, Colorado, United States of America.
Lee JK; Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, United States of America.
Diamond JR; University of Colorado Cancer Center, University of Colorado Denver, Aurora, Colorado, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2014 Feb 05; Vol. 9 (2), pp. e86532. Date of Electronic Publication: 2014 Feb 05 (Print Publication: 2014).
Typ publikacji:: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:: Models, Biological*
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/metabolism
Ovarian Neoplasms*/mortality
Biomarkers, Tumor/*metabolism
Adult ; Aged ; Aged, 80 and over ; Disease-Free Survival ; Female ; Humans ; Middle Aged ; Survival Rate